Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

A single-center study of Wingspan stents for symptomatic atherosclerotic stenosis of the middle cerebral artery.

Zhang L, Huang Q, Zhang Y, Deng B, Liu J, Hong B, Xu Y, Zhao W.

J Clin Neurosci. 2013 Mar;20(3):362-6. doi: 10.1016/j.jocn.2012.03.033. Epub 2012 Dec 8.

PMID:
23228656
2.

Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation.

Zhang L, Huang Q, Zhang Y, Liu J, Hong B, Xu Y, Zhao W.

AJNR Am J Neuroradiol. 2012 Feb;33(2):343-7. doi: 10.3174/ajnr.A2772. Epub 2011 Dec 15.

3.

Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.

Rohde S, Seckinger J, Hähnel S, Ringleb PA, Bendszus M, Hartmann M.

Int J Stroke. 2013 Feb;8(2):87-94. doi: 10.1111/j.1747-4949.2011.00715.x. Epub 2012 Feb 1.

PMID:
22296983
4.

Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50-99% intracranial atherosclerosis: single center experience in 51 cases.

Wolfe TJ, Fitzsimmons BF, Hussain SI, Lynch JR, Zaidat OO.

J Neurointerv Surg. 2009 Jul;1(1):40-3. doi: 10.1136/jnis.2009.000331. Epub 2009 Jul 3.

PMID:
21994104
5.

Treatment of high risk symptomatic intracranial atherosclerosis with balloon mounted coronary stents and Wingspan stents: single center experience over a 10 year period.

Tarlov N, Jahan R, Saver JL, Sayre JW, Ali LK, Kim D, Duckwiler GR, Tateshima S, Viñuela F, Liebeskind DS.

J Neurointerv Surg. 2012 Jan 1;4(1):34-9. doi: 10.1136/jnis.2010.004523. Epub 2011 Jul 28.

PMID:
21990460
6.

Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center.

Miao ZR, Feng L, Li S, Zhu F, Ji X, Jiao L, Ling F.

Neurosurgery. 2009 Jan;64(1):79-84; discussion 84-5. doi: 10.1227/01.NEU.0000335648.31874.37.

PMID:
19050657
7.

Safety and Efficacy of Wingspan Stenting for Severe Symptomatic Atherosclerotic Stenosis of the Middle Cerebral Artery: Analysis of 278 Continuous Cases.

Zhao T, Zhu WY, Xiong XY, Li J, Wang L, Ding HY, Wei F, Zhou Y, Gong ZL, Cheng SY, Liu Y, Shuai J, Yang QW.

J Stroke Cerebrovasc Dis. 2016 Oct;25(10):2368-72. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.035. Epub 2016 Jun 17.

PMID:
27324301
8.
9.

Wingspan stenting with modified predilation for symptomatic middle cerebral artery stenosis.

Li J, Zhao ZW, Gao GD, Cheng JM.

Catheter Cardiovasc Interv. 2011 Aug 1;78(2):286-93. doi: 10.1002/ccd.22755. Epub 2011 Apr 8.

PMID:
20824757
10.

Intracranial angioplasty with Gateway-Wingspan system for symptomatic atherosclerotic stenosis: preliminary results of 27 Chinese patients.

Zhao ZW, Deng JP, He SM, Qin HZ, Gao L, Gao GD.

Surg Neurol. 2009 Dec;72(6):607-11; discussion 611. doi: 10.1016/j.surneu.2009.06.017.

PMID:
20082830
11.

Angiographic patterns of Wingspan in-stent restenosis.

Albuquerque FC, Levy EI, Turk AS, Niemann DB, Aagaard-Kienitz B, Pride GL Jr, Purdy PD, Welch BG, Woo HH, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ.

Neurosurgery. 2008 Jul;63(1):23-7; discussion 27-8. doi: 10.1227/01.NEU.0000335067.53190.A2.

PMID:
18728565
12.

Learning curve of Wingspan stenting for intracranial atherosclerosis: single-center experience of 95 consecutive patients.

Yu SC, Leung TW, Lee KT, Wong LK.

J Neurointerv Surg. 2014 Apr 1;6(3):212-8. doi: 10.1136/neurintsurg-2012-010593. Epub 2013 Mar 20.

13.

A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.

Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ.

Neurosurgery. 2007 Aug;61(2):236-42; discussion 242-3.

PMID:
17762735
14.
15.

MRI audit of complications in intracranial stenosis treated with Wingspan device.

Yeo LL, Wu YM, Chen YL, Yeh CH, Lee TH, Wong HF.

J Neurointerv Surg. 2017 May;9(5):466-470. doi: 10.1136/neurintsurg-2016-012799. Epub 2016 Dec 16.

PMID:
27986847
16.

[Biodiv Ysio stent for symptomatic stenosis of middle cerebral artery].

Jiang WJ, Du B, Wang YJ, Jin M, Wang SX, Dai JP.

Zhonghua Nei Ke Za Zhi. 2004 Apr;43(4):254-7. Chinese.

PMID:
15130406
17.

Influence of patient age and stenosis location on wingspan in-stent restenosis.

Turk AS, Levy EI, Albuquerque FC, Pride GL Jr, Woo H, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella D.

AJNR Am J Neuroradiol. 2008 Jan;29(1):23-7. Epub 2007 Nov 7.

18.

[A long-term follow-up results of Enterprise stent in treatment of severe symptomatic basilar artery atherosclerotic stenosis].

Zhao Y, Jin M, Liu Q, Liu D, Chen J, Du B.

Zhonghua Nei Ke Za Zhi. 2016 May 1;55(5):372-6. doi: 10.3760/cma.j.issn.0578-1426.2016.05.008. Chinese.

PMID:
27143187
19.

Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting.

Wang ZL, Gao BL, Li TX, Cai DY, Zhu LF, Bai WX, Xue JY, Li ZS.

Eur J Radiol. 2015 Sep;84(9):1801-4. doi: 10.1016/j.ejrad.2015.05.033. Epub 2015 Jun 5.

PMID:
26119803
20.

Target lesion revascularization after wingspan: assessment of safety and durability.

Fiorella DJ, Levy EI, Turk AS, Albuquerque FC, Pride GL Jr, Woo HH, Welch BG, Niemann DB, Purdy PD, Aagaard-Kienitz B, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG.

Stroke. 2009 Jan;40(1):106-10. doi: 10.1161/STROKEAHA.108.525774. Epub 2008 Oct 16.

Supplemental Content

Support Center